Connection
John Curtin to Camptothecin
This is a "connection" page, showing publications John Curtin has written about Camptothecin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.034 |
|
|
|
-
Musa F, Pothuri B, Blank SV, Ling HT, Speyer JL, Curtin J, Boyd L, Li X, Goldberg JD, Muggia F, Tiersten A. Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer. Gynecol Oncol. 2017 Feb; 144(2):279-284.
Score: 0.034